Oncolytics Biotech (ONCY) - 2024 Q2 - Earnings Call Transcript

Oncolytics Biotech Inc. (NASDAQ:ONCY) Q2 2024 Results Conference Call August 1, 2024 4:30 PM ET Company Participants Jon Patton - Director of Investor Relations and Communication Wayne Pisano - Chair of Oncolytics' Board of Directors, and Interim CEO Tom Heineman - Chief Medical Officer Christophe Degois - Vice President Business Development Kirk Look - Chief Financial Officer Conference Call Participants John Newman - Canaccord Soumit Roy - Jones Research Michael Okunewitch - Maxim Group Rahul Sarugaser - ...